Why the study?
Although NLR, PLR, and MPV serve as prognostic markers in cancer and thrombotic diseases, their prognostic value in patients undergoing surgery for intracardiac masses is unknown.
Key points are not available for this paper at this time.
Population
Patients undergoing surgery for intracardiac masses
Answers are grounded in this paper and cite their sources.
Objectives: Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and mean platelet volume (MPV) are hematological markers used as prognostic markers in cancer and thrombotic diseases. These markers' association with intracardiac masses is unknown. Our goal is to determine the value of NLR, PLR, and MPV as prognostic markers in patients undergoing surgery for intracardiac masses.
No takes yet. Share an insight, caveat, or question.
Arıkan et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: